Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular Diseases

Go back to Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular Diseases
(NASDAQ: GRML) Delayed: 0.22 --0 (-0%)
Previous Close $0.22    52 Week High
Open $0.22    52 Week Low
Day High $0.22    P/E N/A 
Day Low $0.22    EPS
Volume 1,357,906